LISGARA Trademark

Trademark Overview

On Friday, March 25, 2005, a trademark application was filed for LISGARA with the United States Patent and Trademark Office. The USPTO has given the LISGARA trademark a serial number of 78595569. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 18, 2009. This trademark is owned by Bristol-Myers Squibb & Gilead Sciences,LLC. The LISGARA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of infectious diseases, disorders and conditions, pulmonary diseases, disorders and conditions, and pulmonary hypertension
lisgara

General Information

Serial Number78595569
Word MarkLISGARA
Filing DateFriday, March 25, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 18, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of infectious diseases, disorders and conditions, pulmonary diseases, disorders and conditions, and pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 31, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb & Gilead Sciences,LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFoster City, CA 94404
Party NameBristol-Myers Squibb & Gilead Sciences,LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Monday, May 18, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 18, 2009ABANDONMENT - NO USE STATEMENT FILED
Friday, October 3, 2008EXTENSION 3 GRANTED
Friday, October 3, 2008EXTENSION 3 FILED
Friday, October 3, 2008TEAS EXTENSION RECEIVED
Tuesday, April 15, 2008EXTENSION 2 GRANTED
Tuesday, April 15, 2008EXTENSION 2 FILED
Tuesday, April 15, 2008TEAS EXTENSION RECEIVED
Friday, September 14, 2007EXTENSION 1 GRANTED
Friday, September 14, 2007EXTENSION 1 FILED
Friday, September 14, 2007TEAS EXTENSION RECEIVED
Tuesday, April 17, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2007NOTICE OF PUBLICATION
Monday, December 4, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 4, 2006ASSIGNED TO LIE
Wednesday, November 15, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 3, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 18, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 18, 2006FINAL REFUSAL MAILED
Thursday, May 18, 2006FINAL REFUSAL WRITTEN
Thursday, April 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 20, 2005NON-FINAL ACTION MAILED
Wednesday, October 19, 2005NON-FINAL ACTION WRITTEN
Wednesday, October 19, 2005ASSIGNED TO EXAMINER
Thursday, March 31, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

lisgara disorders conditions pulmonary diseases hypertension infectious preparations human treatment pharmaceutical